综述

新一代测序技术在遗传性耳聋基因研究及诊断中的应用

展开
  • 解放军总医院耳鼻咽喉研究所,北京 100853
作者/通讯袁慧军,博士,研究员,研究方向:聋病分子遗传学。Tel: 010-68156794

收稿日期: 2014-07-01

  网络出版日期: 2014-10-28

基金资助

国家杰出青年科学基金项目(编号:81125008)和国家重点基础研究发展计划(973计划)(编号:2013CB945400)资助

Application of next generation sequencing in gene identification and genetic diagnosis of hereditary hearing loss

Expand
  • Institute of Otolaryngology, Chinese PLA General Hospital, Beijing 100853, China

Received date: 2014-07-01

  Online published: 2014-10-28

摘要

超过50%的耳聋由遗传基因缺陷所致,伴随着基因组学技术的发展,耳聋分子遗传学研究逐渐成为耳科学研究的前沿领域。新一代高通量测序技术的出现,提供了以数据为导向的新的遗传性疾病研究模式,革新了人们对遗传性疾病的认识过程,使得对遗传性疾病的研究策略也发生了重大转变。近年来新一代测序技术(Next generation sequencing,NGS)在耳聋研究中的应用,大大加快了耳聋基因发现的速度,并逐渐向临床应用方向转化。文章总结了遗传性耳聋的特点和研究现状,以及新一代测序技术在耳聋研究中的应用和前景,以及基于NGS技术的耳聋基因研究和临床耳聋基因诊断的发展方向。

本文引用格式

袁慧军, 卢宇 . 新一代测序技术在遗传性耳聋基因研究及诊断中的应用[J]. 遗传, 2014 , 36(11) : 1112 -1120 . DOI: 10.3724/SP.J.1005.2014.1112

Abstract

More than 50% cases with hearing loss are caused by genetic defects. With the development of genomics technology, molecular genetics of hearing loss has become a cutting-edge field under investigation in otology. The next generation sequencing has provided a new model originated from sequencing data to genetic disease study, and has made a revolutionary change in the strategy of gene identification for genetic diseases. Due to the application of next generation sequencing technology, gene identification of hearing loss has been accelerated in recent years, and moreover, the new technology and strategy were explored to clinical application. In this review, we briefly introduce the current situation of hereditary hearing loss research, and the application and perspective of next generation sequencing in this field.

参考文献

[1] 于丽玫, 曲成毅, 梁巍, 王琦, 魏志云. 中国听力残疾构成特点及康复对策. 中国听力语言康复科学杂志, 2008, (2): 21–24.
[2] 中国出生缺陷防治报告. 2012.
[3] MS, DeLuca AP, Taylor KR, Hoskinson DP, Hur IA, Tack D, McMordie SJ, Huygen PLM, Casavant TL, Smith RJH. A contemporary review of AudioGene audioprofiling: a machine-based candidate gene prediction tool for autosomal dominant nonsyndromic hearing loss. Laryngoscope , 2009, 119(11): 2211–2215.
[4] D, Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet , 2003, 33(Suppl): 228–237.
[5] N, Smith RJH, Van Camp G. Forty-six genes cau-sing nonsyndromic hearing impairment: which ones should be analyzed in DNA diagnostics? Mutat Res , 2009, 681(2–3): 189–196.
[6] NH, Prucka SK, Woolley AL, Smith RJH. The use of genetic testing in the evaluation of hearing impairment in a child. Curr Opin Pediatr , 2005, 17(6): 709–712.
[7]
[8]
[9]
[10] P, Oitmaa E, Messner A, Hoefsloot L, Metspalu A, Schrijver I. Simultaneous multigene mutation detection in patients with sensorineural hearing loss through a novel diagnostic microarray: a new approach for newborn screening follow-up. Pediatrics , 2006, 118(3): 985–994.
[11] J, Pique L, Colen T, Roberson J, Gardner P, Schrijver I. Genotyping with a 198 mutation arrayed primer extension array for hereditary hearing loss: assess-ment of its diagnostic value for medical practice. PLoS ONE , 2010, 5(7): e11804.
[12] K, Manji SSM, Hutchison WM, Du Sart D, Phelan D, Dahl HHM. Detection of mutations in genes associated with hearing loss using a microarray-based approach. J Mol Diagn , 2006, 8(4): 483–489; quiz 528.
[13] P, Cox S, Ebert J, Husami A, Kenna MA, Greinwald JH, Aronow BJ, Rehm HL. High-throughput detection of mutations responsible for childhood hearing loss using resequencing microarrays. BMC Biotechnol , 2010, 10: 10.
[14]
[15] S, Yamaguchi T, Usami SI. Application of deafness diagnostic screening panel based on deafness mutation/gene database using invader assay. Genet Test , 2007, 11(3): 333–340.
[16] BG, Clark RH, Kelleher AS, Lin ZL, Spitzer AR, Pediatrix SoundGene® Study Group Principal Investigators and Contributors. Utility of genetic testing for the detection of late-onset hearing loss in neonates. Am J Audiol , 2013, 22(2): 209–215.
[17]
[18] A, Melnikov A, Maguire J, Rogov P, LeProust EM, Brockman W, Fennell T, Giannoukos G, Fisher S, Russ C, Gabriel S, Jaffe DB, Lander ES, Nusbaum C. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol , 2009, 27(2): 182–189.
[19] A, Quackenbush J, Thompson JF. What would you do if you could sequence everything? Nat Biotechnol , 2008, 26: 1125–1133.
[20] MJ, Chen R, Lam HYK, Karczewski KJ, Chen R, Euskirchen G, Butte AJ, Snyder M. Performance comparison of exome DNA sequencing technologies. Nat Biotechnol , 2011, 29: 908–914.
[21] AU, Morell RJ, Belyantseva IA, Khan SY, Boger ET, Shahzad M, Ahmed ZM, Riazuddin S, Khan SN, Riazuddin S, Friedman TB. Targeted capture and next- generation sequencing identifies C9orf75, encoding taperin, as the mutated gene in nonsyndromic deafness DFNB79. Am J Hum Genet , 2010, 86(3): 378–388.
[22] A, Walsh T, Akay H, Spiliopoulos M, Sakalar YB, Hasanefendioğlu-Bayrak A, Duman D, Farooq A, King MC, Tekin M. MASP1 mutations in patients with facial, umbilical, coccygeal, and auditory findings of Carnevale, Malpuech, OSA, and Michels syndromes. Am J Hum Genet , 2010, 87(5): 679–686.
[23] AK, Gandia M, Frommolt P, Maak A, Wicklein EM, Thiele H, Altmuller J, Wagner F, Viñuela A, Aguirre LA, Moreno F, Maier H, Rau I, Gießelmann S, Nürnberg G, Gal A, Nürnberg P, Hübner CA, del Castillo I, Kurth I. Nonsense mutati
文章导航

/